SUBSCRIBE
SUBSCRIBE
News   Deals

Reliant Pharmaceuticals, Inc. Sets IPO at 11.7 Million Shares, $25-$27

October 25, 2007 | 
1 min read
WASHINGTON, Oct 24 (Reuters) - Reliant Pharmaceuticals Inc on Wednesday set its planned initial public offering at 11.72 million shares for an estimated price of $25 to $27 each.
IPO
MORE ON THIS TOPIC
Half open secret door new opportunities concept vector illustration, fear of the unknown, step inside the future, what is behind, what is there.
Earnings
Merck drops early-stage TROP ADC, keeps deal doors open as Keytruda clock ticks
April 30, 2026
 · 
5 min read
 · 
Gabrielle Masson
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Avalyn beats expectations with $300M debut
April 30, 2026
 · 
11 min read
 · 
Editorial Team
Vector of a small businessman supported by unknown investor bridging the gap in his career path
Earnings
With growth curve trending up, Biogen looks to early-stage assets for ‘next generation’
April 29, 2026
 · 
3 min read
 · 
Annalee Armstrong
Business handshake trendy halftone art collage banner template. Partnership concept, successful agreement, closing a deal, securing a contract. Modern retro cut out vector illustration
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
April 29, 2026
 · 
2 min read
 · 
Gabrielle Masson